Targetable alterations in primary extranodal diffuse large B‐cell lymphoma

Targetable alterations in primary extranodal diffuse large B‐cell lymphoma

Abstract Primary extranodal diffuse large B‐cell lymphoma (PE‐DLBCL) is a heterogeneous subgroup of DLBCL. We investigated the prevalence and prognostic value of surface expression of PD‐L1, PD1, and CD30, copy number of 9p24.1 (PD‐L1 region), and mutations in MYD88, CD79B, CARD11, and BTK in a coho...

Full description

Bibliographic Details
Main Authors: Stephanie E. Weissinger, Rucha Dugge, Miriam Disch, Thomas F. Barth, Johannes Bloehdorn, Malena Zahn, Ralf Marienfeld, Andreas Viardot, Peter Möller
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:eJHaem
Subjects:
extranodal diffuse large B‐cell lymphoma
immunohistochemical analysis
mutational analysis
prognosis
targeted therapy
Online Access:https://doi.org/10.1002/jha2.428

Internet

https://doi.org/10.1002/jha2.428

Similar Items